These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 29956532)

  • 21. Benzodiazepines, methadone and buprenorphine: interactions and clinical management.
    Lintzeris N; Nielsen S
    Am J Addict; 2010; 19(1):59-72. PubMed ID: 20132123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Consumer attitudes about opioid addiction treatment: a focus group study in New York City.
    Sohler NL; Weiss L; Egan JE; López CM; Favaro J; Cordero R; Cunningham CO
    J Opioid Manag; 2013; 9(2):111-9. PubMed ID: 23709320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transdermal buprenorphine to switch patients from higher dose methadone to buprenorphine without severe withdrawal symptoms.
    Hess M; Boesch L; Leisinger R; Stohler R
    Am J Addict; 2011; 20(5):480-1. PubMed ID: 21838850
    [No Abstract]   [Full Text] [Related]  

  • 24. Rapid transition from methadone to buprenorphine using naltrexone-induced withdrawal: A case report.
    Ward HB; Barnett BS; Suzuki J
    Subst Abus; 2019; 40(2):140-145. PubMed ID: 30888254
    [No Abstract]   [Full Text] [Related]  

  • 25. Chronic opioid use during pregnancy: maternal and fetal implications.
    Stanhope TJ; Gill LA; Rose C
    Clin Perinatol; 2013 Sep; 40(3):337-50. PubMed ID: 23972743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies.
    Sordo L; Barrio G; Bravo MJ; Indave BI; Degenhardt L; Wiessing L; Ferri M; Pastor-Barriuso R
    BMJ; 2017 Apr; 357():j1550. PubMed ID: 28446428
    [No Abstract]   [Full Text] [Related]  

  • 27. Buprenorphine and methadone for opioid addiction during pregnancy.
    Mozurkewich EL; Rayburn WF
    Obstet Gynecol Clin North Am; 2014 Jun; 41(2):241-53. PubMed ID: 24845488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maternal Opioid Treatment: Human Experimental Research (MOTHER) Study: maternal, fetal and neonatal outcomes from secondary analyses.
    Bandstra ES
    Addiction; 2012 Nov; 107 Suppl 1():1-4. PubMed ID: 23106922
    [No Abstract]   [Full Text] [Related]  

  • 29. Efficacy versus effectiveness of buprenorphine and methadone maintenance in pregnancy.
    Newman RG; Gevertz SG
    J Addict Dis; 2011 Oct; 30(4):318-22. PubMed ID: 22026523
    [No Abstract]   [Full Text] [Related]  

  • 30. Torsades de pointes with high-dose loperamide.
    Kozak PM; Harris AE; McPherson JA; Roden DM
    J Electrocardiol; 2017; 50(3):355-357. PubMed ID: 28109524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methadone and Buprenorphine for Opioid Dependence During Pregnancy: A Retrospective Cohort Study: Re: Meyer et al.
    McCarthy JJ
    J Addict Med; 2016; 10(2):133-4. PubMed ID: 26985649
    [No Abstract]   [Full Text] [Related]  

  • 32. Variation in use of buprenorphine and methadone treatment by racial, ethnic, and income characteristics of residential social areas in New York City.
    Hansen HB; Siegel CE; Case BG; Bertollo DN; DiRocco D; Galanter M
    J Behav Health Serv Res; 2013 Jul; 40(3):367-77. PubMed ID: 23702611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use and misuse of opioid replacement therapies: a Queensland study.
    Smirnov A; Kemp R
    Subst Use Misuse; 2012 Jan; 47(1):78-85. PubMed ID: 22216993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of heroin abstinence in opiate substitution therapy in heroin-only users and dual users of heroin and crack.
    Heidebrecht F; MacLeod MB; Dawkins L
    Addict Behav; 2018 Feb; 77():210-216. PubMed ID: 29065377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outpatient comparison of buprenorphine and methadone maintenance. I. Effects on opiate use and self-reported adverse effects and withdrawal symptomatology.
    Johnson RE; Fudala PJ; Jaffe JH
    NIDA Res Monogr; 1990; 105():585-6. PubMed ID: 1876130
    [No Abstract]   [Full Text] [Related]  

  • 36. The SUMMIT trial: a field comparison of buprenorphine versus methadone maintenance treatment.
    Pinto H; Maskrey V; Swift L; Rumball D; Wagle A; Holland R
    J Subst Abuse Treat; 2010 Dec; 39(4):340-52. PubMed ID: 20817384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. QT interval screening in methadone maintenance treatment: report of a SAMHSA expert panel.
    Martin JA; Campbell A; Killip T; Kotz M; Krantz MJ; Kreek MJ; McCarroll BA; Mehta D; Payte JT; Stimmel B; Taylor T; Haigney MC; Wilford BB;
    J Addict Dis; 2011 Oct; 30(4):283-306. PubMed ID: 22026519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fetal neurobehavioral effects of exposure to methadone or buprenorphine.
    Jansson LM; Dipietro JA; Velez M; Elko A; Williams E; Milio L; O'Grady K; Jones HE
    Neurotoxicol Teratol; 2011; 33(2):240-3. PubMed ID: 20868741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Actigraphic measurements in opioid detoxification with methadone or buprenorphine.
    Pjrek E; Frey R; Naderi-Heiden A; Strnad A; Kowarik A; Kasper S; Winkler D
    J Clin Psychopharmacol; 2012 Feb; 32(1):75-82. PubMed ID: 22198453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetic interactions between darunavir/ritonavir and opioid maintenance therapy using methadone or buprenorphine/naloxone.
    Sekar V; Tomaka F; Lefebvre E; De Pauw M; Vangeneugden T; van den Brink W; Hoetelmans R
    J Clin Pharmacol; 2011 Feb; 51(2):271-8. PubMed ID: 20421512
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.